Scientific Program

Friday, April 5, 2019
OVARIAN CANCER

LIVE SURGERY
Moderation: A. du Bois, L. Chiva, B. Monk
Ovarian Cancer and Sarcomas
Surgeons: R. Chekerov, C. Fotopoulou, M. Z. Muallem, G. Scambia, J. Sehouli

during Live Surgery:
The Most Challenging Case of the Year
G. Inci


Lunch Break

LECTURES AND PRO/CON SESSIONS

Chair: L. Chiva, W. A. Cliby


HIPEC: Hype or Hope?
C. Fotopoulou


Pro/Con: Surgery in Relapsed Ovarian Cancer
Pro: A. du Bois
Con: T. Herzog


Role of Lymph Node Dissection in Early, Low and High Grade Ovarian Cancer
W. A. Cliby


Role of Lymph Node Dissection in Advanced Ovarian Cancer
J. Sehouli


Prediction of Surgical Outcome: Tumor Biology vs. Surgical Skills
E. I. Braicu


Coffee Break

Chair: A. González Martín, J. Sehouli


PARP Therapies: Who are the Best Candidates and Who Not?
J. Ledermann


Role of Antiangiogenesis inGynecological Malignancies: Who are the Best Candidates and Who Not?
S. Pignata


Low Grade Ovarian Cancer: Best Medical Treatment
B. Monk


Immunotherapy in Ovarian Cancer: How to Optimize the Benefits
O. Dorigo


New Targeted Therapies in Breast Cancer and Gynecological Cancers: Prevention and Management of Complication
K. Pietzner


Similarities and Differences of Asian and Non-Asian Gynecological Cancer Patients
K. Fujiwara


End of program



Program Information